Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancer

Antonio Gualberto, Daniel D. Karp

Research output: Contribution to journal › Review article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences